INS and type 2 diabetes mellitus: We aimed our current expert position to update the prior published algorithm on the most suitable choice of CGM for insulin-treated PwD in light of the recent evidence reporting the efficacy and safety of CGM in type 1 and type 2 diabetes [7–9], and clinical practice.